The Global Antibiotic Research and Development Partnership (GARDP) Not-for-Profit Model of Antibiotic Development
The Global Antibiotic Research and Development Partnership (GARDP) brings together public and private partners to accelerate the development and global availability of new antibiotics to treat the most challenging drug-resistant bacterial infections. Established in 2016, GARDP’s recently launched strategy sets out its ambitious aim to deliver five new treatments by 2025, focusing on sexually transmitted infections, sepsis in newborns, and infections in hospitalized adults and children.
Join the AMR Insights Ambassador Network today!
Connect to over 550 AMR professionals and students in 60 countries!